| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $25,408,606 | 14 | 100 |
| Adams Jennifer McKie | director | 0 | $0 | 1 | $1.62M | $-1.62M |
| MAIER PAUL V | director | 0 | $0 | 1 | $2.95M | $-2.95M |
| Krempa David | Chief Business Officer | 0 | $0 | 5 | $5.09M | $-5.09M |
| Opaleye Management Inc. | 10 percent owner | 0 | $0 | 4 | $5.83M | $-5.83M |
| BRYNJELSEN SEAN | President & CEO | 0 | $0 | 3 | $9.91M | $-9.91M |
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing …
Over the last 12 months, insiders at Eton Pharmaceuticals, Inc. have bought $0 and sold $25.41M worth of Eton Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Eton Pharmaceuticals, Inc. have bought $388,450 and sold $10.77M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 7,930 shares for transaction amount of $125,484 was made by Opaleye Management Inc. (10 percent owner) on 2025‑06‑10.
| 2026-10-06 | Sale | Krempa David | Chief Business Officer | 4,166 0.0153% | $55.07 | $229,406 | -6.44% | |
| 2026-08-28 | Sale | MAIER PAUL V | director | 50,000 0.1804% | $59.07 | $2.95M | -7.61% | |
| 2026-08-24 | Sale | Krempa David | Chief Business Officer | 25,000 0.0913% | $65.07 | $1.63M | -14.12% | |
| 2026-08-20 | Sale | BRYNJELSEN SEAN | President & CEO | 91,022 0.3367% | $60.70 | $5.53M | -7.48% | |
| 2026-08-19 | Sale | BRYNJELSEN SEAN | President & CEO | 8,978 0.0334% | $62.65 | $562,472 | -9.73% | |
| 2026-07-14 | Sale | Opaleye Management Inc. | 10 percent owner | 28,315 0.1035% | $37.54 | $1.06M | +43.08% | |
| 2026-07-07 | Sale | Opaleye Management Inc. | 10 percent owner | 26,685 0.0983% | $38.37 | $1.02M | +39.19% | |
| 2026-07-06 | Sale | Opaleye Management Inc. | 10 percent owner | 10,000 0.0365% | $38.00 | $380,000 | +37.24% | |
| 2026-07-02 | Sale | Opaleye Management Inc. | 10 percent owner | 90,000 0.3276% | $37.39 | $3.36M | +38.88% | |
| 2026-06-17 | Sale | Adams Jennifer McKie | director | 50,000 0.1832% | $32.48 | $1.62M | +55.85% | |
| 2026-05-28 | Sale | BRYNJELSEN SEAN | President & CEO | 120,000 0.4384% | $31.88 | $3.83M | +55.84% | |
| 2026-05-27 | Sale | Krempa David | Chief Business Officer | 19,679 0.0698% | $31.47 | $619,375 | +52.16% | |
| 2026-05-26 | Sale | Krempa David | Chief Business Officer | 37,524 0.1332% | $31.49 | $1.18M | +57.43% | |
| 2026-05-22 | Sale | Krempa David | Chief Business Officer | 42,797 0.1601% | $33.39 | $1.43M | +51.03% | |
| 2025-08-20 | Sale | Gruber James R. | Chief Financial Officer | 2,631 0.0095% | $16.02 | $42,149 | +14.92% | |
| 2025-08-19 | Sale | Gruber James R. | Chief Financial Officer | 39,082 0.1454% | $16.16 | $631,565 | +17.35% | |
| 2025-06-16 | Sale | Krempa David | Chief Business Officer | 10,223 0.0396% | $14.73 | $150,585 | +22.94% | |
| 2025-06-13 | Sale | Krempa David | Chief Business Officer | 6,800 0.0262% | $14.77 | $100,436 | +21.40% | |
| 2025-06-12 | Sale | Krempa David | Chief Business Officer | 16,977 0.0651% | $14.92 | $253,297 | +19.37% | |
| 2025-06-10 | Opaleye Management Inc. | 10 percent owner | 7,930 0.0298% | $15.82 | $125,484 | +10.12% |
| BRYNJELSEN SEAN | President & CEO | 961194 3.3628% | $48.97M | 7 | 6 | <0.0001% |
| MAIER PAUL V | director | 59745 0.209% | $3.04M | 1 | 1 | +7.11% |
| Opaleye Management Inc. | 10 percent owner | 40000 0.1399% | $2.04M | 8 | 21 | +99.22% |
| CASAMENTO CHARLES J | director | 71920 0.2516% | $3.66M | 2 | 0 | +1.97% |
| RIEDEL NORBERT G | director | 59745 0.209% | $3.04M | 1 | 0 | +7.11% |
| Troutman William Wilson | CFO, Treasurer & Secretary | 23027 0.0806% | $1.17M | 2 | 0 | <0.0001% |
| BAUM MARK L | director | 10000 0.035% | $509,500.00 | 1 | 0 | +7.11% |
| Increased Positions | 49 | +38.28% | 974,857 | +5.52% |
| Decreased Positions | 56 | -43.75% | 3M | -15.58% |
| New Positions | 21 | New | 291,177 | New |
| Sold Out Positions | 19 | Sold Out | 892,157 | Sold Out |
| Total Postitions | 121 | -5.47% | 16M | -10.06% |
| Opaleye Management Inc. | $46,504.00 | 10.59% | 2.86M | 0 | 0% | 2025-09-30 |
| Ecor1 Capital, Llc | $33,017.00 | 7.52% | 2.03M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $27,713.00 | 6.31% | 1.7M | +172,650 | +11.27% | 2025-09-30 |
| Vanguard Group Inc | $21,855.00 | 4.98% | 1.34M | +31,942 | +2.43% | 2025-09-30 |
| Nantahala Capital Management, Llc | $19,121.00 | 4.36% | 1.18M | 0 | 0% | 2025-09-30 |
| Morgan Stanley | $9,529.00 | 2.17% | 586,046 | +76,478 | +15.01% | 2025-09-30 |
| Geode Capital Management, Llc | $9,334.00 | 2.13% | 574,030 | -18,835 | -3.18% | 2025-09-30 |
| Royal Bank Of Canada | $7,792.00 | 1.78% | 479,193 | +474,128 | +9,360.87% | 2025-09-30 |
| Westside Investment Management, Inc. | $7,684.00 | 1.75% | 472,540 | -250 | -0.05% | 2025-09-30 |
| Cannell Capital Llc | $7,405.00 | 1.69% | 455,405 | +67,230 | +17.32% | 2025-09-30 |